The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDuke Capital Regulatory News (DUKE)

Share Price Information for Duke Capital (DUKE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 32.75
Bid: 32.50
Ask: 33.00
Change: 0.25 (0.76%)
Spread: 0.50 (1.538%)
Open: 32.75
High: 33.50
Low: 33.00
Prev. Close: 32.75
DUKE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Re-Admission and First Day of Dealings

23 Mar 2017 17:00

RNS Number : 3903A
Duke Royalty Limited
23 March 2017
 

 

Duke Royalty Limited

("Duke Royalty" or the "Company")

 

Re-Admission and First Day of Dealings

 

St. Peter Port, Guernsey - March 23, 2017 - Duke Royalty Limited, a public diversified royalty company (AIM: DUKE), is pleased to announce the commencement of dealings earlier today in its ordinary shares having successfully raised £15 million before expenses (the "Fundraising"), as announced on 17 March 2017.

The Company's Nominated Adviser, Grant Thornton UK LLP, advised the Company in relation to its re-admission to AIM and Fundraising and Cantor Fitzgerald Europe and Mirabaud Securities LLP acted as Joint Brokers to the Company.

 

SUMMARY

· Pursuant to the Fundraising, a total of 37,500,000 New Shares have been successfully placed or subscribed for in the Company at a price of 40 pence per share (the "Issue Price"), with new and existing institutional investors, as well as certain Directors.

· Gross proceeds of £15.0 million (net proceeds £13.8 million after expenses) were raised pursuant to the Fundraising which will be used for the Company's inaugural royalty investments and working capital, in anticipation of delivering its maiden dividend to shareholders.

· The Company is pleased to have several significant institutional shareholders holding over 3 per cent. of the Company, including Hargreaves Hale, Brookfield's Partner Value Investments Inc., AXA Investment Managers, Artemis Investment Management, and Henderson Global Investors.

· The number of ordinary shares in issue immediately after Re-admission is 45,377,459, giving the Company a market capitalisation of approximately £21.6 million as at market close.

Commenting on the re-admission to AIM and the Fundraising, Neil Johnson, Chief Executive Officer, said:

"Duke Royalty is the first quoted diversified royalty company in Europe, and we look forward to bringing our alternative financing solutions to the European marketplace to help fill the funding gap for well-run, profitable, private companies across Europe and abroad.

"The Board has been delighted by the support of its new investors which are some of the largest investment managers in the world. The quality of our investors and exclusive global collaboration partner Oliver Wyman validates our belief in the exciting opportunity to bring royalty financing to European companies and UK investors. We look forward to delivering value for our shareholders in the months and years ahead."

 

Other than where defined, capitalised terms used in the announcement have the meanings given to them in the Fundraising announcement of 17 March 2017.

 

For further information, please contact:

 

Duke Royalty Limited

Neil Johnson / Charlie Cannon-Brookes

+44 (0) 1481 741 240

Grant Thornton UK LLP (Nominated Adviser)

Colin Aaronson / Samantha Harrison / Jamie Barklem/ Carolyn Sansom

+44 (0) 20 7383 5100

Cantor Fitzgerald Europe (Joint Broker)

Marc Milmo / Catherine Leftley / Callum Butterfield

+44 (0) 207 894 7000

Mirabaud Securities LLP (Joint Broker)

Peter Krens / Edward Haig-Thomas

+44 (0) 20 3167 7222

 

About Duke Royalty

Headquartered in Guernsey, Duke Royalty Limited provides alternative financing solutions to a diversified range of businesses in Europe and abroad. Duke Royalty's experienced team and exclusive partnership provide financing solutions to private companies that are in need of capital but whose owners wish to maintain equity control of their business. Duke Royalty's royalty investments are intended to provide robust, stable, long term returns to its shareholders.

Duke Royalty is quoted on AIM, a market operated by the London Stock Exchange, under the ticker DUKE. For more information, visit dukeroyalty.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AIMPGURCWUPMGQW
Date   Source Headline
22nd Jun 20173:19 pmRNSFinal Results and Maiden Dividend
22nd Jun 20177:00 amRNSFinal Results
9th Jun 20177:00 amRNSRoyalty Partner Operational Update
6th Apr 20177:00 amRNSInaugural royalty financing agreement
28th Mar 20177:00 amRNSHolding(s) in Company
24th Mar 20172:55 pmRNSHolding(s) in Company
23rd Mar 20175:00 pmRNSRe-Admission and First Day of Dealings
22nd Mar 20173:45 pmRNSSch 1 Update - Duke Royalty Limited
20th Mar 20179:35 amRNSSch 1 Update - Duke Royalty Limited
17th Mar 20176:17 pmRNSResult of Fundraising
16th Mar 20175:03 pmRNSProposed Placing and Subscription
21st Feb 201711:25 amRNSSch 1 Update - Duke Royalty Limited
1st Feb 201711:00 amRNSSchedule 1 - Duke Royalty Limited
11th Jan 20177:01 amRNSAppointment of Chief Investment Officer
11th Jan 20177:00 amRNSChange of Advisors and Operational Update
17th Nov 20169:00 amRNSUnaudited interim results
1st Sep 201612:02 pmRNSResult of AGM
25th Jul 20167:00 amRNSFinal Results
29th Mar 20161:32 pmRNSSale of investments
7th Mar 20167:00 amRNSBoard Changes and Corporate Update
3rd Feb 20167:00 amRNSDirector/PDMR Shareholding
19th Jan 20169:55 amRNSChange of Adviser
14th Dec 201511:40 amRNSDirector/PDMR Shareholding
23rd Nov 20157:00 amRNSInterim results
29th Oct 20157:00 amRNSHolding(s) in Company
29th Oct 20157:00 amRNSCorrection: Appointment and Issue of Shares
28th Oct 20157:00 amRNSMr Justin Cochrane Appointment and Issue of Shares
12th Oct 20155:16 pmRNSHolding(s) in Company
17th Sep 20153:40 pmRNSFormation of Healthcare Investment Committee
14th Sep 201512:41 pmRNSHolding(s) in Company
11th Sep 20157:00 amRNSDirector share purchase
10th Sep 201512:00 pmRNSResult of AGM
7th Sep 20159:15 amRNSGrant of options
7th Sep 20157:00 amRNSPlacing
7th Sep 20157:00 amRNSCollaboration with Oliver Wyman
4th Aug 201512:21 pmRNSChanges to NAV Reporting
27th Jul 20154:12 pmRNSResults for the year ended 31 March 2015
16th Jun 201511:36 amRNSResult of EGM
10th Jun 201511:21 amRNSHolding(s) in Company
2nd Jun 20151:57 pmRNSHolding(s) in Company
28th May 201511:00 amRNSEGM, proposed changes to board & investing policy
26th May 20159:58 amRNSHolding(s) in Company
26th May 20159:57 amRNSHolding(s) in Company
26th May 20159:56 amRNSHolding(s) in Company
26th May 20159:56 amRNSHolding(s) in Company
22nd May 20155:15 pmRNSRepayment of zero dividend preference shares
20th May 20157:00 amRNSPlacing
15th May 201511:08 amRNSSale of investment
20th Apr 20155:36 pmRNSNet Asset Value(s)
19th Jan 20154:27 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.